Jazz Pharmaceuticals PLC (JAZZ)

Receivables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	4,068,943	3,992,713	3,909,883	3,843,380	3,834,209	3,794,392	3,762,904	3,738,465	3,659,374	3,583,982	3,481,445	3,300,378	3,094,238	2,863,024	2,625,797	2,436,422	2,363,567	2,279,790	2,216,604	2,188,301
Receivables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $4,068,943K ÷ $—K
= —

The receivables turnover ratio for Jazz Pharmaceuticals PLC could not be calculated as there is insufficient information provided in the dataset. The receivables turnover ratio is a financial metric used to analyze how efficiently a company is managing its receivables by measuring the number of times a company collects its average accounts receivable balance during a specific period.

Without the specific values for accounts receivable and sales figures for the corresponding periods, it is not possible to compute the receivables turnover ratio accurately. A higher receivables turnover ratio generally indicates that a company is collecting its outstanding receivables more quickly, which is favorable as it signifies efficient credit management. Conversely, a lower ratio could suggest potential issues with collecting payments from customers in a timely manner.

To provide a more in-depth analysis of Jazz Pharmaceuticals PLC's receivables turnover, detailed financial data for accounts receivable and sales across multiple periods would be necessary to calculate the ratio and draw meaningful conclusions about the company's efficiency in managing its receivables.